Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies ADAR1 Capital Management, LLC files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Vivo Opportunity, LLC - $434K in INM purchases and sales in the last 12 months
- Simcere Zaiming, Inc. - $185K in NXTC purchases and sales in the last 12 months
- Declan Doogan - $102K in TENX purchases and sales in the last 12 months
- Thomas McGauley - $58K in TENX purchases and sales in the last 12 months
- Stuart Rich - $46K in TENX purchases and sales in the last 12 months
- Christopher Thomas Giordano - $40K in TENX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
What is ADAR1 Capital Management, LLC?
ADAR1 Capital Management, LLC is an investment firm, tracked as 10% Owner of NextCure, Inc. (NXTC). InsiderAlpha holds 20 primary Form 4 filings for it, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has ADAR1 Capital Management, LLC submitted recently?
11 primary Form 4 filings in the last 90 days, covering 3 companies.
Has ADAR1 Capital Management, LLC been buying or selling stock?
Recorded transactions: 59 open-market purchases ($13.19M) and 3 open-market sales ($95.66M) across all tracked filings.
